Improvement in self-reported physical functioning with tiotropium/olodaterol in Central and Eastern European COPD patients

A Valipour, M Tamm, J Kociánová, V Bayer… - … journal of chronic …, 2019 - Taylor & Francis
Background Reduced physical activity is associated with increased morbidity and mortality
in patients with COPD. Studies suggest that treatment with the long-acting muscarinic …

[PDF][PDF] Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients

A Valipour, M Tamm, J Kociánová… - … Journal of Chronic …, 2019 - scienceopen.com
Background: Reduced physical activity is associated with increased morbidity and mortality
in patients with COPD. Studies suggest that treatment with the long-acting muscarinic …

Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients.

A Valipour, M Tamm, J Kociánová, V Bayer… - International journal of …, 2019 - sonar.ch
Methods An international, open-label, single-arm, non-interventional study conducted in
nine countries measuring changes in self-reported physical functioning in COPD patients …

Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients.

A Valipour, M Tamm, J Kociánová, V Bayer… - International journal of …, 2019 - folia.unifr.ch
Methods An international, open-label, single-arm, non-interventional study conducted in
nine countries measuring changes in self-reported physical functioning in COPD patients …

Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients

A Valipour, C Toma, A Belevskiy, B Matula… - International Journal of …, 2019 - hero.epa.gov
Background: Reduced physical activity is associated with increased morbidity and mortality
in patients with COPD. Studies suggest that treatment with the long-acting muscarinic …

Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients

A Valipour, M Tamm, J Kociánová, V Bayer… - … Journal of Chronic …, 2019 - dovepress.com
Background: Reduced physical activity is associated with increased morbidity and mortality
in patients with COPD. Studies suggest that treatment with the long-acting muscarinic …

Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients.

A Valipour, M Tamm, J Kocianova, V Bayer… - International Journal of …, 2019 - go.gale.com
Patients with COPD are less active. This can cause a patient's quality of life to decrease, and
they may need more visits to hospital. However, treatment with drugs that open the airways …

[PDF][PDF] Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients

A Valipour, M Tamm, J Kociánová, V Bayer… - International Journal of …, 2019 - academia.edu
Background: Reduced physical activity is associated with increased morbidity and mortality
in patients with COPD. Studies suggest that treatment with the long-acting muscarinic …

[HTML][HTML] Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients

A Valipour, M Tamm, J Kociánová, V Bayer… - … Journal of Chronic …, 2019 - ncbi.nlm.nih.gov
Background Reduced physical activity is associated with increased morbidity and mortality
in patients with COPD. Studies suggest that treatment with the long-acting muscarinic …

[PDF][PDF] Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients

A Valipour, M Tamm, J Kociánová, V Bayer… - International Journal of …, 2019 - nczisk.sk
Background: Reduced physical activity is associated with increased morbidity and mortality
in patients with COPD. Studies suggest that treatment with the long-acting muscarinic …